FIT test
Selected indexed studies
- Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial. (JAMA Neurol, 2022) [PMID:35499850]
- DBS of Thalamic Centromedian Nucleus for Lennox-Gastaut Syndrome (ESTEL Trial). (Ann Neurol, 2022) [PMID:34877694]
- PTZ-induced seizures in mice require a revised Racine scale. (Epilepsy Behav, 2019) [PMID:31026782]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial. (2022) pubmed
- DBS of Thalamic Centromedian Nucleus for Lennox-Gastaut Syndrome (ESTEL Trial). (2022) pubmed
- PTZ-induced seizures in mice require a revised Racine scale. (2019) pubmed
- Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial. (2021) pubmed
- Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures. (2020) pubmed
- Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial. (2021) pubmed
- Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial. (2022) pubmed
- The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. (2023) pubmed
- Adjunctive perampanel for partial-onset seizures. (2018) pubmed
- Introduction. (2010) pubmed